Maria Greenwald

机构：Desert Medical Imaging, Foundation for the Advancement in Research in Medicine · ORCID：0000-0002-2622-1448

发表论文 99 篇 · 总被引 9773 次 · h-index 35

代表论文

• Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study (2016 · Annals of the Rheumatic Diseases · 被引 407)
• Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis (2014 · New England Journal of Medicine · 被引 396)
• Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial (2018 · The Lancet · 被引 374)
• Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1) (2016 · Annals of the Rheumatic Diseases · 被引 238)
• Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2) (2016 · Annals of the Rheumatic Diseases · 被引 234)
• Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial (2019 · The Lancet · 被引 218)